OARV-771 is a derivative of ARV-771, which is a potent PROTAC targeting bromodomain and extraterminal (BET) proteins, utilizing the von Hippel-Lindau E3 ligase for targeted degradation. This compound features selective binding affinity for various BRD proteins, demonstrating its potential utility in research focused on modulating BET protein functions.
Usually ships within 24 hours.